Biopharma Co. Gets Nod For $4.5M Ch. 11 Sale Of Drug Rights
Biopharmaceutical company Achaogen Inc. received approval Thursday in Delaware bankruptcy court for a $4.5 million sale of Chinese intellectual property and distributions rights related to its plazomicin antibiotic drug after two...To view the full article, register now.
Already a subscriber? Click here to view full article